EarningsQ3 2021 Earnings Report

Laboratorios Farmaceuticos Rovi (ROVIN) Q3 2021 Earnings Report

― Followers

MX:ROVIN Q3 2021 EPS Results

Actual EPS$17.91

Consensus EPS―

Beat/Miss―

One Year Ago EPS$6.40

Actual Revenue$3.57B

Expected Revenue$3.13B

Beat/MissBeat by +$438.71M

YoY Revenue Growth+56.24%

QuarterQ3 2021

Date11/03/2021

TimeTBA

Conference CallWednesday, November 3, 2021

MX:ROVIN Upcoming Earnings

Laboratorios Farmaceuticos Rovi's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	- / -	23.35	―
Jul 23, 2026	2026 (Q2)	- / 30.19	8.71	246.57% (+21.48)
May 06, 2026	2026 (Q1)	- / 3.81	7.289	-47.74% (-3.48)
Feb 25, 2026	2025 (Q4)	- / 17.17	9.41	82.49% (+7.76)
Nov 06, 2025	2025 (Q3)	- / 23.35	17.708	31.86% (+5.64)
Jul 24, 2025	2025 (Q2)	- / 8.71	17.708	-50.81% (-9.00)
May 08, 2025	2025 (Q1)	- / 7.29	5.951	22.49% (+1.34)
Feb 25, 2025	2024 (Q4)	- / 9.41	20.467	-54.02% (-11.06)
Nov 07, 2024	2024 (Q3)	- / 28.09	20.138	39.47% (+7.95)
Jul 31, 2024	2024 (Q2)	- / 17.71	7.413	138.89% (+10.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed